AAAAAA

   
Results: 1-17 |
Results: 17
Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors
Authors: Rad, AN Schlom, J Hodge, JW
Citation: An. Rad et al., Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors, CR R ONC H, 39(1-2), 2001, pp. 43-57
Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules
Authors: Hodge, JW Grosenbach, DW Rad, AN Giuliano, M Sabzevari, H Schlom, J
Citation: Jw. Hodge et al., Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules, VACCINE, 19(25-26), 2001, pp. 3552-3567
Acquisition of CD80 (B7-1) by T cells
Authors: Sabzevari, H Kantor, J Jaigirdar, A Tagaya, Y Naramura, M Hodge, JW Bernon, J Schlom, J
Citation: H. Sabzevari et al., Acquisition of CD80 (B7-1) by T cells, J IMMUNOL, 166(4), 2001, pp. 2505-2513
Synergy of vaccine strategies to amplify antigen-specific immune responsesand antitumor effects
Authors: Grosenbach, DW Barrientos, JC Schlom, J Hodge, JW
Citation: Dw. Grosenbach et al., Synergy of vaccine strategies to amplify antigen-specific immune responsesand antitumor effects, CANCER RES, 61(11), 2001, pp. 4497-4505
Carcinoembryonic antigen as a vaccine target
Authors: Schlom, J Tsang, KY Hodge, JW Greiner, JW
Citation: J. Schlom et al., Carcinoembryonic antigen as a vaccine target, IMMUNOL MED, 30, 2001, pp. 73-100
Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules
Authors: Hodge, JW Rad, AN Grosenbach, DW Sabzevari, H Yafal, AG Gritz, L Schlom, J
Citation: Jw. Hodge et al., Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules, J NAT CANC, 92(15), 2000, pp. 1228-1239
PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+Tcells in vitro
Authors: Baker, EJ Ichiki, AT Hodge, JW Sugantharaj, D Bamberger, EG Lozzio, CB
Citation: Ej. Baker et al., PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+Tcells in vitro, LEUK RES, 24(12), 2000, pp. 1049-1057
Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity
Authors: Freund, YR Mirsalis, JC Fairchild, DG Brune, J Hokama, LA Schindler-Horvat, J Tomaszewski, JE Hodge, JW Schlom, J Kantor, JA Tyson, CA Donohue, SJ
Citation: Yr. Freund et al., Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity, INT J CANC, 85(4), 2000, pp. 508-517
Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L)
Authors: Lorenz, MGO Kantor, JA Schlom, J Hodge, JW
Citation: Mgo. Lorenz et al., Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L), HUM GENE TH, 10(7), 1999, pp. 1095-1103
Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus (vol 10, pg 623, 1999)
Authors: Lorenz, MGO Kantor, JA Schlom, J Hodge, JW
Citation: Mgo. Lorenz et al., Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus (vol 10, pg 623, 1999), HUM GENE TH, 10(7), 1999, pp. 1260-1260
Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus
Authors: Lorenz, MGO Kantor, JA Schlom, J Hodge, JW
Citation: Mgo. Lorenz et al., Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus, HUM GENE TH, 10(4), 1999, pp. 623-631
The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation
Authors: Kalus, RM Kantor, JA Gritz, L Yafal, AG Mazzara, GP Schlom, J Hodge, JW
Citation: Rm. Kalus et al., The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation, VACCINE, 17(7-8), 1999, pp. 893-903
Strategies in the development of recombinant vaccines for colon cancer
Authors: Schlom, J Tsang, KY Kantor, JA Abrams, SI Zaremba, S Greiner, J Hodge, JW
Citation: J. Schlom et al., Strategies in the development of recombinant vaccines for colon cancer, SEMIN ONCOL, 26(6), 1999, pp. 672-682
A triad of costimulatory molecules synergize to amplify T-cell activation
Authors: Hodge, JW Sabzevari, H Yafal, AG Gritz, L Lorenz, MGO Schlom, J
Citation: Jw. Hodge et al., A triad of costimulatory molecules synergize to amplify T-cell activation, CANCER RES, 59(22), 1999, pp. 5800-5807
Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines
Authors: Hodge, JW Schlom, A
Citation: Jw. Hodge et A. Schlom, Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines, CANCER RES, 59(20), 1999, pp. 5106-5111
Differential regulation of interleukin-1 alpha and interleukin-1 beta in K-562 cells
Authors: Ichiki, AT Langenberg, M Baker, EJ Hodge, JW Bamberger, EG Gerard, DA Lozzio, CB
Citation: At. Ichiki et al., Differential regulation of interleukin-1 alpha and interleukin-1 beta in K-562 cells, J INTERF CY, 18(12), 1998, pp. 1045-1050
The informal communication network: Factors influencing grapevine activity
Authors: Crampton, SM Hodge, JW Mishra, JM
Citation: Sm. Crampton et al., The informal communication network: Factors influencing grapevine activity, PUBL PERS M, 27(4), 1998, pp. 569-584
Risultati: 1-17 |